Bowen Hanes & CO Inc Pfizer Inc Transaction History

Bowen Hanes & CO Inc

$3.8 Billion
Q3 2024

A detailed history of Bowen Hanes & CO Inc transactions in Pfizer Inc stock. As of the latest transaction made, Bowen Hanes & CO Inc holds 61,471 shares of PFE stock, worth $1.64 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

61,471

Previous 64,471 4.65%

Holding current value

$1.64 Million

Previous $1.8 Million 1.39%

% of portfolio

0.05%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $83,100 - $94,170	-3,000 Reduced 4.65%	61,471 $1.78 Million
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $6,946 - $8,140	-275 Reduced 0.42%	64,471 $1.8 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $166,787 - $216,639	-6,383 Reduced 8.97%	64,746 $1.86 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $154,032 - $180,048	4,800 Added 7.24%	71,129 $2.36 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $5,418 - $6,268	150 Added 0.23%	66,329 $2.43 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $12,801 - $16,666	-325 Reduced 0.49%	66,179 $2.7 Million
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $384,308 - $501,672	9,205 Added 16.06%	66,504 $3.41 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $1.18 Million - $1.43 Million	-26,856 Reduced 31.91%	57,299 $2.51 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $34,897 - $41,377	750 Added 0.9%	84,155 $4.41 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $116,662 - $144,559	-2,550 Reduced 2.97%	83,405 $4.32 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $169,288 - $250,941	-4,097 Reduced 4.55%	85,955 $5.08 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $2,747 - $3,529	-70 Reduced 0.08%	90,052 $3.87 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $244,498 - $310,900	7,305 Added 8.82%	90,122 $3.32 Million
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $54,610 - $64,070	1,720 Added 2.12%	82,817 $3.04 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $332,675 - $403,584	11,045 Added 15.77%	81,097 $2.65 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $216,332 - $242,892	-5,850 Reduced 7.71%	70,052 $3.04 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $575,362 - $632,131	-15,343 Reduced 16.82%	75,902 $3.22 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $746,318 - $850,884	19,400 Added 27.0%	91,245 $3.98 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $27,576 - $33,448	-800 Reduced 1.1%	71,845 $3.17 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $48,645 - $51,860	-1,475 Reduced 1.99%	72,645 $2.64 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $2.3 Million - $2.53 Million	74,120	74,120 $2.65 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bowen Hanes & CO Inc with notifications on news.

Account

Bowen Hanes & CO Inc Pfizer Inc Transaction History